Providence Capital Advisors’s Accelerate Diagnostics AXDX Stock Holding History

Providence Capital Advisors’s Portfolio AXDX Stock Details AXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-4	Closed	-$7	–	135
2024 Q3	$7	Hold	4	–	–	﹤0.01%	353
2024 Q2	$5	Hold	4	–	–	﹤0.01%	355
2024 Q1	$4	Hold	4	–	–	﹤0.01%	342
2023 Q4	$16	Hold	4	–	–	﹤0.01%	334
2023 Q3	$23	Sell	4 -1	-20%	-$7	﹤0.01%	349
2023 Q2	$40	Hold	5	–	–	﹤0.01%	308
2023 Q1	$34	Hold	5	–	–	﹤0.01%	306
2022 Q4	$35	Hold	5	–	–	﹤0.01%	296
2022 Q3	$0	Hold	5	–	–	﹤0.01%	319
2022 Q2	$0	Hold	5	–	–	﹤0.01%	299
2022 Q1	$0	Hold	5	–	–	﹤0.01%	461
2021 Q4	$0	Hold	5	–	–	﹤0.01%	339
2021 Q3	$0	Hold	5	–	–	﹤0.01%	303
2021 Q2	$0	Hold	5	–	–	﹤0.01%	307
2021 Q1	$0	Hold	5	–	–	﹤0.01%	282
2020 Q4	$0	Hold	5	–	–	﹤0.01%	317
2020 Q3	$1K	Hold	5	–	–	﹤0.01%	206
2020 Q2	$1K	Hold	5	–	–	﹤0.01%	170
2020 Q1	$0	Hold	5	–	–	﹤0.01%	241
2019 Q4	$1K	Hold	5	–	–	﹤0.01%	249
2019 Q3	$1K	Hold	5	–	–	﹤0.01%	214
2019 Q2	$1K	Hold	5	–	–	﹤0.01%	228
2019 Q1	$1K	Hold	5	–	–	﹤0.01%	267
2018 Q4	$1K	Hold	5	–	–	﹤0.01%	243
2018 Q3	$1K	Hold	5	–	–	﹤0.01%	252
2018 Q2	$1K	Hold	5	–	–	﹤0.01%	246
2018 Q1	$1K	Hold	5	–	–	﹤0.01%	240
2017 Q4	$1K	Buy	+5	New	+$1.17K	﹤0.01%	301

Other funds holding AXDX

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

GAM

Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cannell & Spears New York $5.62B AUM 41.25% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BAM

Belpointe Asset Management Reno, Nevada $3.06B AUM 23.82% 1-Year Est. Return

TWA

TCI Wealth Advisors Tucson, Arizona $2.31B AUM 26.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Providence Capital Advisors's AXDX Position: Q4 2024 in Review

Providence Capital Advisors sold out of Accelerate Diagnostics (AXDX) in Q4 2024, closing a stake of 4 shares — an estimated $7 sold.

Providence Capital Advisors first reported a position in AXDX in Q4 2017 and held it in 28 quarters. The position peaked at $1K in Q3 2020. 47 funds tracked by Wall St. Rank hold AXDX as of Q4 2024.

Providence Capital Advisors reported no remaining Accelerate Diagnostics position as of Q4 2024 after selling out during the quarter.
Providence Capital Advisors sold 4 Accelerate Diagnostics shares in Q4 2024, an estimated $7.
Providence Capital Advisors first reported a position in Accelerate Diagnostics in Q4 2017 and held it in 28 quarters.
Providence Capital Advisors's Accelerate Diagnostics position peaked at $1K in Q3 2020.
47 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q4 2024.

Based on Providence Capital Advisors's 13F filing for Q4 2024, filed 12 Feb 2025.